
Singapore's CDA Named WHO Collaborating Centre for Infection Prevention
Illustration: NexVani Media
The World Health Organization has designated Singapore's Communicable Diseases Agency as a collaborating centre to boost global infection prevention and control efforts.
The World Health Organization (WHO) has officially designated Singapore's Communicable Diseases Agency (CDA) as a collaborating centre for infection prevention and control (IPC), marking a significant milestone in international health cooperation. This development, announced on Monday, November 16, positions the CDA as the first WHO centre globally focused on strengthening health systems specifically through IPC frameworks. Individuals searching for Singapore CDA information will find that this new status elevates the agency's role in global health security.
As a designated collaborating centre, the CDA will actively contribute to international efforts aimed at combating infectious diseases while benefiting from the exchange of technical expertise with global partners. The agency plans to work in close coordination with the WHO to advance IPC standards across 38 member states within the Western Pacific region, an area that includes nations such as Australia, China, Japan, South Korea, and Malaysia.
Advancing global health standards for Singapore CDA
Dr. Sylvie Brand, the WHO chief scientist, noted that the CDA brings substantial experience and expertise to the international stage, which will be instrumental in driving progress across the Western Pacific. This collaboration is expected to enhance preparedness for future infectious disease threats and provide better protection for both healthcare workers and patients in Singapore.
The CDA is now the first WHO collaborating centre dedicated to strengthening health systems through infection control.
Adjunct Associate Professor Kalisvar Marimuthu, who heads the WHO collaborating centre at the CDA, emphasized that infection prevention and control is fundamental to the safety of medical environments. He stated that the designation creates a valuable opportunity for Singapore to share its local expertise internationally while simultaneously learning from global partners to refine domestic practices. The ultimate goal of this knowledge exchange is to make healthcare safer for everyone involved.
This appointment follows the recent launch of the CDA by Prime Minister Lawrence Wong on November 12, 2025. The agency was established to bolster Singapore's readiness for future pandemics, reflecting the government's recognition that new challenges continue to emerge from infectious diseases.
Why it matters
The designation of the CDA as a WHO collaborating centre signifies a major step in regional health integration. By formalizing this partnership, Singapore gains a platform to lead in IPC policy, which directly affects the safety standards of healthcare systems across the Western Pacific.
For the broader region, this initiative means more robust, collaborative responses to infectious threats. It ensures that best practices are shared across borders, helping to protect healthcare workers and patients in member states by creating a more resilient and prepared medical infrastructure.
Sources
More like this

Lindsay Clancy to Face Retrial for Deaths of Her Three Children

NIH Scientists Face Pressure to Align Research with Administration Priorities

Inquest examines infant deaths linked to unregistered birth support in NSW

